GlassScriptPhysician profile
Lisa Rogers
NPI 1316900517
$3,514.52
in general payments reported to CMS, 2019-2025
24 companies · $309 in 2025
The $309 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $779 · 2020: $137 · 2021: $273 · 2022: $693 · 2023: $715 · 2024: $608 · 2025: $309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,632.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,631.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $959.21 | 2023-2025 | Myfembree, Gemtesa |
| Myovant Sciences INC. | $462.27 | 2022 | |
| Abbvie INC. | $397.00 | 2019-2023 | Lo Loestrin Fe, Orilissa, Liletta |
| Medtronic USA, INC. | $256.63 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $244.95 | 2019-2025 | |
| Evofem Biosciences, INC. | $162.44 | 2020-2023 | Phexxi |
| Pfizer INC. | $146.22 | 2019-2024 | |
| Covidien LP | $138.60 | 2019 | |
| Hologic Sales and Service, LLC | $135.07 | 2019-2024 | Aptima, Omni Hysteroscope, Fluent Fluid Management System |
| Astellas Pharma US INC | $121.13 | 2023-2025 | Veozah |
| Amag Pharmaceuticals, INC. | $95.37 | 2019 | |
| Mayne Pharma Commercial LLC | $85.49 | 2022-2023 | |
| Millicent US INC | $45.18 | 2024-2025 | Intrarosa, Femlyv, Femring |
| Allergan, INC. | $45.12 | 2019 | |
| Scynexis, INC. | $38.89 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $36.61 | 2019 | |
| Agile Therapeutics, INC. | $24.95 | 2022-2023 | Twirla |
| Axonics, INC. | $24.50 | 2023 | Axonics, Bulkamid |
| Amgen INC. | $20.42 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.88 | 2019 | |
| Galderma Laboratories, L.P. | $15.75 | 2025 | |
| Exact Sciences Corporation | $14.63 | 2025 | The Cologuard Plus Collection Kit |
| Avion Pharmaceuticals | $14.07 | 2023 | Balcoltra |
| Lupin INC. | $13.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Rogers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.